Johanna Mercier Gilead Sciences, Inc. (GILD) insider trading activity

Johanna Mercier is Chief Commercial Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 75,140 shares of GILD, which is worth approximately $7.02 Million. The most recent transaction as insider was on Jan 24, 2023, when has been sold 15,325 shares (Common Stock) at a price of $84.02 per share, resulting in proceeds of $1,287,606. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.1K

3.82% 3M change

17.4% 12M change

Total Value Held $7.02 Million

Johanna Mercier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 24 2023	SELL Payment of exercise price or tax liability	$1,287,606 $84.02 p/Share	15,325 Reduced 16.71%	76,365 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	67,394 Added 42.36%	91,690 Common Stock
Dec 10 2022	SELL Payment of exercise price or tax liability	$40,730 $87.97 p/Share	463 Reduced 1.13%	40,430 Common Stock
Dec 10 2022	BUY Exercise of conversion of derivative security	-	990 Added 2.36%	40,893 Common Stock
Sep 10 2022	SELL Payment of exercise price or tax liability	$29,898 $65.28 p/Share	458 Reduced 1.13%	39,903 Common Stock
Sep 10 2022	BUY Exercise of conversion of derivative security	-	990 Added 2.39%	40,361 Common Stock
Jul 24 2022	SELL Payment of exercise price or tax liability	$194,925 $60.8 p/Share	3,206 Reduced 7.53%	39,371 Common Stock
Jul 24 2022	BUY Exercise of conversion of derivative security	-	7,505 Added 14.99%	42,577 Common Stock
Jun 10 2022	SELL Payment of exercise price or tax liability	$28,062 $60.74 p/Share	462 Reduced 1.3%	35,072 Common Stock
Jun 10 2022	BUY Exercise of conversion of derivative security	-	990 Added 2.71%	35,534 Common Stock
Mar 10 2022	SELL Payment of exercise price or tax liability	$186,560 $57.92 p/Share	3,221 Reduced 8.53%	34,544 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	-	6,987 Added 15.61%	37,765 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	18,630 Added 37.71%	30,778 Common Stock
Jul 24 2021	SELL Payment of exercise price or tax liability	$236,393 $69.02 p/Share	3,425 Reduced 21.99%	12,148 Common Stock
Jul 24 2021	BUY Exercise of conversion of derivative security	-	7,505 Added 32.52%	15,573 Common Stock
May 04 2021	SELL Open market or private sale	$1,288,491 $66.09 p/Share	19,496 Reduced 70.73%	8,068 Common Stock
Mar 10 2021	SELL Payment of exercise price or tax liability	$91,711 $63.91 p/Share	1,435 Reduced 4.95%	27,564 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	-	3,025 Added 9.45%	28,999 Common Stock
Jan 26 2021	BUY Grant, award, or other acquisition	-	8,068 Added 23.7%	25,974 Common Stock
Nov 03 2020	SELL Payment of exercise price or tax liability	$722,550 $58.83 p/Share	12,282 Reduced 40.69%	17,906 Common Stock
Nov 03 2020	BUY Grant, award, or other acquisition	-	26,270 Added 46.53%	30,188 Common Stock

Also insider at

NBIX

NEUROCRINE BIOSCIENCES INC Healthcare

Director

Johanna Mercier

Chief Commercial Officer

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account